Pieter Wesseling
#127,059
Most Influential Person Now
Researcher
Pieter Wesseling's AcademicInfluence.com Rankings
Pieter Wesselingcomputer-science Degrees
Computer Science
#5393
World Rank
#5701
Historical Rank
Artificial Intelligence
#1648
World Rank
#1680
Historical Rank
Database
#2545
World Rank
#2666
Historical Rank
Download Badge
Computer Science
Pieter Wesseling's Degrees
- PhD Computer Science University of Amsterdam
- Masters Artificial Intelligence University of Amsterdam
- Bachelors Computer Science University of Amsterdam
Similar Degrees You Can Earn
Why Is Pieter Wesseling Influential?
(Suggest an Edit or Addition)Pieter Wesseling's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. (2009) (6397)
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. (2021) (2388)
- DNA methylation-based classification of central nervous system tumours (2018) (1461)
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas (2009) (1062)
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma (2011) (871)
- The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells (2013) (637)
- Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. (2015) (622)
- RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics (2015) (620)
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs (2016) (608)
- Diffuse glioma growth: a guerilla war (2007) (546)
- International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading (2014) (514)
- WHO 2016 Classification of gliomas (2018) (470)
- IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group (2010) (393)
- Germline mutation of INI1/SMARCB1 in familial schwannomatosis. (2007) (342)
- DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly (2014) (300)
- cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading (2020) (293)
- Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study (2017) (271)
- Molecular diagnostics of gliomas: state of the art (2010) (271)
- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas (2015) (261)
- Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations (2001) (254)
- In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. (2010) (251)
- cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant (2018) (251)
- Development and developmental disorders of the human cerebellum (2003) (245)
- IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO (2015) (241)
- Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra (2006) (234)
- Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains (2006) (226)
- CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo (2007) (226)
- Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option (2004) (224)
- LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS (2019) (223)
- Angiogenesis in brain tumors; pathobiological and clinical aspects (1997) (219)
- Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets (2017) (211)
- Receptor conversion in distant breast cancer metastases (2010) (209)
- Glioma: experimental models and reality (2017) (207)
- Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. (2009) (204)
- Heparan sulphate proteoglycans in Alzheimer's disease and amyloid‐related disorders (2003) (189)
- Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. (1994) (189)
- Prognostic significance and mechanism of Treg infiltration in human brain tumors (2010) (184)
- Classification of Gliomas (2013) (182)
- MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas (2007) (176)
- The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. (2014) (173)
- EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. (2017) (171)
- Histologic classification of gliomas. (2016) (157)
- Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. (2002) (153)
- Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring. (2018) (151)
- Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. (2000) (149)
- Early and Extensive Contribution of Pericytes/Vascular Smooth Muscle Cells to Microvascular Proliferation in Glioblastoma Multiforme: An Immuno‐light and Immuno‐electron Microscopic Study (1995) (149)
- Oligodendroglioma: pathology, molecular mechanisms and markers (2015) (149)
- Sarcoma classification by DNA methylation profiling (2021) (147)
- Aminopeptidase A is a functional target in angiogenic blood vessels. (2004) (145)
- Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment (2015) (133)
- cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC) (2018) (127)
- Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. (1999) (123)
- Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. (1994) (123)
- MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951 (2013) (123)
- Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. (2016) (120)
- Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system (2009) (116)
- Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors. (2006) (115)
- A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951 (2011) (115)
- RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations (2007) (114)
- Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. (1994) (112)
- Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function. (2016) (111)
- Collision sellar lesions: experience with eight cases and review of the literature (2009) (110)
- Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (2016) (109)
- Development and malformations of the human pyramidal tract (2004) (109)
- Molecular pathogenesis of oligodendroglial tumors (2004) (108)
- Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization (2008) (105)
- EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. (2021) (104)
- Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951. (2013) (103)
- Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution (2013) (102)
- Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. (1998) (102)
- Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium (2018) (102)
- In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma (2013) (101)
- Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. (1999) (101)
- Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. (2015) (98)
- Molecular pathology of tumors of the central nervous system (2019) (98)
- Myc‐associated zinc finger protein (MAZ) is regulated by miR‐125b and mediates VEGF‐induced angiogenesis in glioblastoma (2012) (94)
- Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. (2009) (93)
- Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma. (2003) (91)
- Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. (2005) (90)
- Expression pattern of apoptosis-related markers in Huntington’s disease (2005) (90)
- EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. (2017) (85)
- Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases (2012) (85)
- Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue (2015) (85)
- Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments (2009) (81)
- Collagen XVIII: a Novel Heparan Sulfate Proteoglycan Associated with Vascular Amyloid Depositions and Senile Plaques in Alzheimer's Disease Brains (2002) (79)
- Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial (2012) (78)
- Phenotypic and Genotypic Characterization of Orthotopic Human Glioma Models and Its Relevance for the Study of Anti‐glioma Therapy (2008) (77)
- Liquid biopsies in patients with diffuse glioma (2015) (76)
- Accurate classification of childhood brain tumours by in vivo ¹H MRS - a multi-centre study. (2013) (76)
- Vascular endothelial growth factor‐A determines detectability of experimental melanoma brain metastasis in GD‐DTPA‐enhanced MRI. (2003) (75)
- Robust Detection of EGFR Copy Number Changes and EGFR Variant III: Technical Aspects and Relevance for Glioma Diagnostics (2009) (75)
- Keratitis Caused by Scedosporium apiospermum Successfully Treated with a Cornea Transplant and Voriconazole (2003) (74)
- Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. (1997) (73)
- Primary Melanocytic Tumors of the Central Nervous System: a Review with Focus on Molecular Aspects (2015) (73)
- Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2 (2013) (72)
- Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. (1999) (72)
- Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3. (2004) (71)
- The Molecular Landscape of ETMR at Diagnosis and Relapse (2019) (70)
- Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques (2002) (68)
- Protein tyrosine phosphatases in glioma biology (2009) (66)
- Subventricular spread of diffuse intrinsic pontine glioma (2014) (66)
- Subtyping of oligo‐astrocytic tumours by comparative genomic hybridization (2001) (65)
- Histological effects of fibrin glue on nervous tissue: a safety study in rats. (2002) (64)
- Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database. (2006) (64)
- Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas. (2017) (63)
- Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH (2002) (63)
- Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome (2007) (63)
- Monitoring of Tumor Growth and Post‐Irradiation Recurrence in a Diffuse Intrinsic Pontine Glioma Mouse Model (2011) (63)
- cIMPACT‐NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification (2017) (62)
- Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment (2017) (62)
- The pathological diagnosis of diffuse gliomas: towards a smart synthesis of microscopic and molecular information in a multidisciplinary context (2011) (61)
- Human pontine glioma cells can induce murine tumors (2014) (61)
- Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI (2008) (60)
- Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8 (2018) (60)
- P120-catenin dependent collective brain infiltration by glioma cell networks (2019) (60)
- Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis (2010) (59)
- Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. (2013) (57)
- Double‐blind comparison of 5‐aminosalicylic acid and acetyl‐5‐aminosalicylic acid suppositories in patients with idiopathic proctitis (1988) (56)
- Magnetic resonance imaging‐based detection of glial brain tumors in mice after antiangiogenic treatment (2007) (56)
- Reconstructing the molecular life history of gliomas (2017) (56)
- Glioma progression is shaped by genetic evolution and microenvironment interactions (2022) (56)
- Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis (2005) (56)
- Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. (2021) (55)
- Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG (2013) (55)
- A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. (2020) (55)
- MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential (2010) (55)
- Preparing pathology for personalized medicine: possibilities for improvement of the pre‐analytical phase (2011) (53)
- cIMPACT‐NOW: a practical summary of diagnostic points from Round 1 updates (2019) (53)
- Amyloid‐β‐induced Degeneration of Human Brain Pericytes Is Dependent on the Apolipoprotein E Genotype (2000) (53)
- Hypokinesia and presenile dementia in a Dutch family with a novel insertion in the prion protein gene. (1995) (52)
- Heparan sulfate proteoglycan expression in cerebrovascular amyloid β deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains (2001) (52)
- Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers? (2014) (51)
- Progression of a Nelson’s adenoma to pituitary carcinoma; a case report and review of the literature (1999) (49)
- Third harmonic generation imaging for fast, label-free pathology of human brain tumors (2016) (48)
- Giant cavernous hemangiomas: report of three cases (2006) (48)
- Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models (2016) (48)
- Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the A‚-containing lesions in brains of patients with dementia of the Alzheimer type (1996) (47)
- Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient. (2013) (47)
- Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1 (2019) (45)
- 3′-Deoxy-3′-18F-Fluorothymidine PET–Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients (2012) (45)
- Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas. (1995) (45)
- Hypoxia in a human intracerebral glioma model. (2000) (45)
- Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor (2014) (45)
- Chromosomal imbalances in primary oligodendroglial tumors and their recurrences: clues about malignant progression detected using comparative genomic hybridization. (2002) (45)
- AMINOPEPTIDASE A IS A CONSTITUENT OF ACTIVATED PERICYTES IN ANGIOGENESIS (1996) (44)
- Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms (1993) (43)
- Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study (2019) (43)
- Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis (2007) (43)
- Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion: An Intergroup trial. (2016) (42)
- Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. (2014) (41)
- Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial (2020) (41)
- Comparative Genomic Hybridization: Practical Guidelines (2002) (40)
- EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma (2013) (40)
- Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis (2018) (40)
- The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin αvβ3 expression (2001) (40)
- Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma. (2011) (39)
- Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes. (2014) (39)
- Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein (2015) (38)
- Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma (2020) (38)
- Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models (2011) (38)
- The cIMPACT-NOW updates and their significance to current neuro-oncology practice. (2020) (37)
- Choroid plexus carcinoma: a report of two cases and review of the literature. (1996) (37)
- Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin (2020) (37)
- A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era (2021) (36)
- Neuromyelitis optica with clinical and histopathological involvement of the brain (2007) (36)
- Three-dimensional reconstruction of tumor microvasculature: Simultaneous visualization of multiple components in paraffin-embedded tissue (2006) (36)
- Mutations in G Protein Encoding Genes and Chromosomal Alterations in Primary Leptomeningeal Melanocytic Neoplasms (2015) (36)
- Brain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support tool (2020) (35)
- Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data (2016) (35)
- Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours (2015) (35)
- SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas (2016) (35)
- Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis (2017) (35)
- Counting mitoses: SI(ze) matters! (2021) (35)
- Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis (2014) (34)
- Alpha‐internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy (2011) (34)
- A case of Joubert's syndrome with extensive cerebral malformations. (2000) (34)
- Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14 (2019) (33)
- Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases (2014) (33)
- Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I. (2013) (32)
- Gliomatosis cerebri: quantitative proof of vessel recruitment by cooptation instead of angiogenesis. (2005) (31)
- Transalar Sphenoidal Encephalocele and Respiratory Distress in a Neonate: A Case Report (1999) (31)
- Papillary Tumor of the Pineal Region: A Distinct Molecular Entity (2016) (31)
- Suramin Treatment of Human Glioma Xenografts; Effects on Tumor Vasculature and Oxygenation Status (1999) (31)
- The combination of IDH 1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH 1 or MGMT alone (2014) (30)
- Development of the tumor vascular bed in response to hypoxia‐induced VEGF‐A differs from that in tumors with constitutive VEGF‐A expression (2006) (30)
- A pilot study on slit lamp-adapted optical coherence tomography imaging of trabeculectomy filtering blebs (2007) (30)
- Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZ-B differentially regulate glioma cell growth and motility (2014) (30)
- Mitochondrial cytopathy presenting as hereditary sensory neuropathy with progressive external ophthalmoplegia, ataxia and fatal myoclonic epileptic status. (1996) (30)
- Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis (2020) (30)
- Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. (2002) (30)
- Implementation of a multi‐institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture (2013) (29)
- A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann–Sträussler–Scheinker disease phenotype: comparison with similar cases from the literature (2010) (29)
- Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma (2012) (29)
- Characteristic Chromosomal Aberrations in Sporadic Cerebellar Hemangioblastomas Revealed by Comparative Genomic Hybridization (2001) (29)
- Retroclival extradural hematoma is a magnetic resonance imaging diagnosis. (2001) (28)
- Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting. (2013) (28)
- Meningioma of the pituitary stalk without dural attachment: case report and review of the literature. (1999) (28)
- SMARCB1 Involvement in the Development of Leiomyoma in a Patient With Schwannomatosis (2014) (27)
- Letter in Response to David N. Louis et al, International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171 (2014) (27)
- Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas (2014) (27)
- Mapping of the SCA 23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20 p 13-12 . 3 (2004) (26)
- Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype (2018) (26)
- Benign and malignant tumors in Rubinstein–Taybi syndrome (2018) (26)
- Genetic reflection of glioblastoma biopsy material in xenografts: characterization of 11 glioblastoma xenograft lines by comparative genomic hybridization. (2000) (26)
- Primary intracranial germ-cell tumors in adults: a practical review (2013) (26)
- Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma (2017) (26)
- PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion (2019) (26)
- Severe keratitis due to Nocardia farcinica (1997) (25)
- Postmortem findings in the Nijmegen breakage syndrome. (1994) (25)
- Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors (2014) (24)
- Ileus in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. (1998) (24)
- Grading of meningeal solitary fibrous tumors/hemangiopericytomas: analysis of the prognostic value of the Marseille Grading System in a cohort of 132 patients (2019) (24)
- In vivo MR guided boiling histotripsy in a mouse tumor model evaluated by MRI and histopathology (2016) (24)
- Understanding cognitive functioning in glioma patients: The relevance of IDH‐mutation status and functional connectivity (2019) (24)
- Inverse Correlation between Genetic Aberrations and Malignancy Grade in Ependymal Tumors: A Paradox? (2004) (24)
- The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression. (2001) (23)
- Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. (2017) (23)
- The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic “Life Story” (2011) (23)
- Severe tacrolimus leukoencephalopathy after liver transplantation. (2003) (23)
- Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma (2021) (22)
- Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma (2019) (22)
- Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol. (2016) (22)
- Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors (2021) (22)
- Selective cancer-germline gene expression in pediatric brain tumors (2008) (22)
- Regulatory T cells and the PD-L 1 / PD-1 pathway mediate immune suppression in malignant human brain tumors (2009) (21)
- Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations (2021) (21)
- Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra (2011) (20)
- Distinct Differences in Binding Capacity to Saccharide Epitopes in Supratentorial Pilocytic Astrocytomas, Astrocytomas, Anaplastic Astrocytomas, and Glioblastomas (2001) (20)
- Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1 (2020) (20)
- Molecular Diagnostics as a Tool to Personalize Treatment in Adult Glioma Patients (2006) (20)
- Intestinal mucosa on top of a rudimentary occipital meningocele in amniotic rupture sequence: disorganization-like syndrome, homeotic transformation, abnormal surface encounter or endoectodermal adhesion? (2002) (20)
- The Aircardi-Goutières syndrome: variable clinical expression in two siblings. (1997) (20)
- Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma (2016) (19)
- Correlation between contrast enhancement on intraoperative magnetic resonance imaging and histopathology in glioblastoma (2012) (19)
- Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion. (2019) (19)
- Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma (2018) (19)
- PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum (2021) (19)
- Three-dimensional (3D) reconstruction and quantitative analysis of the microvasculature in medulloblastoma and ependymoma subtypes (2006) (19)
- Multiregional Tumor Drug-Uptake Imaging by PET and Microvascular Morphology in End-Stage Diffuse Intrinsic Pontine Glioma (2017) (18)
- Myelopathy due to spinal epidural abscess without cord compression: a diagnostic pitfall. (2004) (18)
- Data Sets for the Reporting of Tumors of the Central Nervous System. (2019) (18)
- Neuropathological diagnostic accuracy (2002) (18)
- Prognostic significance of NAB2–STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear (2019) (18)
- Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas (2015) (18)
- Technical feasibility of integrating 7 T anatomical MRI in image-guided radiotherapy of glioblastoma: a preparatory study (2016) (17)
- Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma (2021) (17)
- Intramedullary enterogenous cyst presenting with spastic paraparesis during two consecutive pregnancies: a case report (2001) (17)
- Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumors (2019) (16)
- White Matter Lesions Are Not Related to β-Amyloid Deposition in an Autopsy-Based Study (2011) (16)
- Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma. (2018) (16)
- A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques (2004) (16)
- Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1 (2021) (15)
- Pituitary apoplexy after mild head injury misinterpreted as bacterial meningitis (2007) (15)
- Quantitative Third Harmonic Generation Microscopy for Assessment of Glioma in Human Brain Tissue (2019) (15)
- Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas. (2014) (14)
- A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule (2006) (14)
- Cyclin D1 Genotype and Expression in Sporadic Hemangioblastomas (2005) (14)
- Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma (2016) (13)
- Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma (2018) (13)
- Incremental Gaussian Discriminant Analysis based on Graybill and Deal weighted combination of estimators for brain tumour diagnosis (2011) (13)
- Embryonal tumor with multilayered rosettes (ETMR): signed, sealed, delivered … (2014) (13)
- Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma (2011) (13)
- 5th International Symposium on Focused Ultrasound (2016) (13)
- Oligosarcomas, IDH-mutant are distinct and aggressive (2021) (12)
- Radiotherapy for partially resected spinal ependymomas: a retrospective study of 60 cases. (2003) (12)
- Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors (2021) (12)
- Multiplex blood reporters for simultaneous monitoring of cellular processes. (2013) (11)
- Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains. (2004) (11)
- Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation (2008) (11)
- Differential patterns of insulin‐like growth factor‐I and ‐II mRNA expression in medulloblastoma (2004) (11)
- CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather (2021) (10)
- Postoperative oscillatory brain activity as an add-on prognostic marker in diffuse glioma (2020) (10)
- OMRT-3. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2021) (10)
- Spatial concordance of DNA methylation classification in diffuse glioma (2021) (10)
- Therapeutic implications of improved molecular diagnostics for rare CNS-embryonal tumor entities: results of an international, retrospective study. (2021) (10)
- A new X linked neurodegenerative syndrome with mental retardation, blindness, convulsions, spasticity, mild hypomyelination, and early death maps to the pericentromeric region (1999) (9)
- Cerebral Amyloid Angiopathy with Severe Secondary Vascular Pathology: A Histopathological Study (2005) (9)
- Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. (2018) (9)
- Molecular tools for the pathologic diagnosis of central nervous system tumors. (2018) (9)
- GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types (2021) (8)
- Detection and localization of early- and late-stage cancers using platelet RNA. (2022) (8)
- Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis. (2017) (8)
- Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients (2012) (8)
- Quantitative parametric maps of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in diffuse glioma (2019) (8)
- A Uniform Histological Cluster Scheme for ICD-O-Coded Primary Central Nervous System Tumors (1998) (8)
- HIGH GRADE GLIOMAS (2012) (8)
- Can excision of meningiomas be limited to resection of tumor and radiologically abnormal dura mater? Neuronavigation-guided biopsies of dural tail and seemingly normal dura mater, with a review of the literature. (2014) (8)
- Genetics and pharmacogenomics of diffuse gliomas. (2013) (8)
- Selective MET Kinase Inhibition in MET-Dependent Glioma Models Alters Gene Expression and Induces Tumor Plasticity (2017) (7)
- QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES DURING MALIGNANT PROGRESSION IN ASTROCYTIC NEOPLASMS (1996) (7)
- Modified core wash cytology (CWC), an asset in the diagnostic work-up of breast lesions. (2010) (7)
- Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells (2016) (7)
- Impact of MR-guided boiling histotripsy in distinct murine tumor models. (2017) (7)
- Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trial. (2022) (7)
- Towards an integrated morphological and molecular WHO diagnosis of central nervous system tumors: a paradigm shift. (2015) (7)
- Molecular Analysis as a Tool in the Differential Diagnosis of VHL Disease-Related Tumors (2005) (6)
- Severe, non X-linked congenital microcephaly with absence of the pyramidal tracts in two siblings (1999) (6)
- Induction of a-Smooth Muscle Actin Expression in Cultured Human Brain Pericytes by Transforming Growth Factor-f31 (2007) (6)
- The Relationship Between Genetic Aberrations as Detected by Comparative Genomic Hybridization and Vascularization in Glioblastoma Xenografts (2004) (6)
- Molecular diagnostics of brain tumors (2010) (6)
- A spinal intradural enterogenous cyst with well-differentiated muscularis propria (2002) (6)
- Non-invasively measured brain activity and radiological progression in diffuse glioma (2021) (6)
- Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis (2017) (5)
- Occurrence of ocular melanoma thirteen years after skin melanoma: two separate primaries or metastatic disease? A case solved with NRAS and CDKN2A (INK4A-ARF) mutational analysis (2008) (5)
- RE: MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION FOR THE DETECTION OF 1P AND 19Q LOSS IN OLIGODENDROGLIAL TUMORS (2005) (5)
- A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern (2015) (5)
- Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (2022) (5)
- ACTR-11. SECOND INTERIM AND 1ST MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CODELETION (2019) (5)
- Computer-assisted analysis of the microvasculature in untreated glioblastomas (2005) (5)
- The Biology of Brain Tumors (2008) (5)
- CHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma (2019) (5)
- Ranking of Brain Tumour Classifiers Using a Bayesian Approach (2009) (5)
- An unusual cause of a cerebral tumour in a young patient. Behçet's disease. (2006) (5)
- WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup? (2020) (5)
- Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma. (2009) (5)
- Unique Presentation of Corneal Opacity in Peters Plus Syndrome: An Unusual Form of Peters Anomaly Showing Tissue Repair in Serial Analysis (2016) (5)
- Virilization due to ovarian androgen hypersecretion in a patient with ectopic adrenocorticotrophic hormone secretion caused by a carcinoid tumour: case report. (2006) (5)
- Direct comparison of [11C] choline and [18F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients (2019) (4)
- Massive reduction of tumour load and normalisation of hyperprolactinaemia after high dose cabergoline in metastasised prolactinoma causing thoracic syringomyelia (2004) (4)
- Re: a Word of Caution on New and Revolutionary Diagnostic Tests. (2016) (4)
- Taxonomy of CNS tumours; a series of three short reviews on the WHO 2016 classification and beyond (2018) (4)
- INTRINSIC MOLECULAR SUBTYPES OF GLIOMA ARE PROGNOSTIC AND PREDICT BENEFIT FROM ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL BRAIN TUMORS: A REPORT FROM EORTC STUDY 26951 (2012) (4)
- An activating germline IDH1 variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoid (2020) (4)
- ACTR-04. RESULTS OF THE INTERIM ANALYSIS OF THE EORTC RANDOMIZED PHASE III CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CO-DELETION, AN INTERGROUP TRIAL (2016) (3)
- Unsuspected cerebral phaeohyphomycosis presenting as chronic basilar meningitis. (1999) (3)
- Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment (2021) (3)
- Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades (2012) (3)
- Immune Responses to Tumours in the CNS (2014) (3)
- Pathology-proven extradural ("distant") metastases of gliomas in adults in the Netherlands between 1971 and 2018: a systematic case series. (2021) (3)
- EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET (2018) (3)
- Clinical characteristics of subsequent histologically confirmed meningiomas in long-term childhood cancer survivors: A Dutch LATER study. (2021) (3)
- Supplemental Information New Brain Tumor Entities Emerge from Molecular Classi fi cation of CNS-PNETs (2016) (3)
- Pathology and Classification of Tumors of the Central Nervous System (2019) (3)
- Clinical presentation, treatment and follow-up of 32 patients with a primary intracranial germinoma; registered during the previous 15 years in the Pathological Anatomical Nationwide Automated Archive. (2000) (3)
- PROGNOSTIC VALUE OF MICROVASCULAR PARAMETERS IN DIFFUSE ASTROCYTIC NEOPLASMS (1999) (3)
- DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2012) (3)
- Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG (2013) (3)
- Advances in Brief Vascular Endothelial Growth Factor-A 165 Induces Progression of Melanoma Brain Metastases without Induction of Sprouting Angiogenesis 1 (2002) (2)
- Digital PCR quanti fi cation of MGMT methylation re fi nes prediction of clinical bene fi t from alkylating agents in glioblastoma and metastatic colorectal cancer (2015) (2)
- Infantile motor neuron disease with autonomic dysfunction and bunina bodies (1997) (2)
- P01.075 Understanding cognitive functioning in diffuse glioma patients: the relevance of IDH mutation status and functional connectivity (2018) (2)
- The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs. (2019) (2)
- Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification (2022) (2)
- Getting to the core of nervous-system tumours P Kleihues WK (2001) (2)
- Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based study (2021) (2)
- Fatal consequences of an ear infection (2009) (2)
- Immunotherapy of Diffuse Gliomas: Helping the Brain Fight Back! (2009) (1)
- Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor (2014) (1)
- PATH-11. PROGNOSTIC SIGNIFICANCE OF EPIGENETIC SUBTYPES AND CpGs ASSOCIATED WITH PROGRESSION TO G-CIMP LOW IN THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON (2020) (1)
- Vascularization of the Brain and Spinal Cord (2020) (1)
- [Development and developmental disorders of the human brain. III. Neuronal migration disorders of the cerebrum]. (2001) (1)
- The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries (2022) (1)
- CBM-16TUMOR-EDUCATED PLATELET-BASED LIQUID BIOPSIES IN GLIOBLASTOMA PATIENTS (2015) (1)
- OMICS AND PROGNSTIC MARKERS (2013) (1)
- OMICS AND PROGNSTIC MARKERS (2013) (1)
- LANDSCAPE OF CHROMOSOMAL COPY NUMBER ABERRATIONS (CNAS) IN GLIONEURONAL TUMORS (GNTS): RELATIVELY FREQUENT GAIN OF CHROMOSOME 5 AND/OR 7; CHROMOTHRIPSIS IN SUBSET OF CASES (2013) (1)
- Comparison between radiological and histopathological diagnoses in a multicentre international brain tumour magnetic resonance database (2002) (1)
- ALL-tRNAseq enables robust tRNA profiling in tissue samples. (2023) (1)
- Higher Harmonic Generation Imaging for Neuropathology (2020) (1)
- [Clinical presentation, treatment, and follow-up of 32 patients with a primary intracranial germinoma, registered during the previous 15 years in the Dutch Pathological-Anatomical National Automated Archive (PALGA)]. (2000) (1)
- Omics and Prognostic Markers (2010) (1)
- Differential expression of heparan sulfate proteoglycans in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. (2001) (1)
- CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA (2020) (1)
- Expression of Mutant SMARCB1 Proteins in Schwannomas of Schwannomatosis Patients (2014) (1)
- The cochlear nuclei in two patients with Usher syndrome type I. (1999) (1)
- The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen (2021) (1)
- Pathology and immune effects of magnetic resonance imaging-guided Boiling Histotripsy in murine tumor models (2016) (1)
- Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial ependymoma (2021) (1)
- DNA methylation classification in diffuse glioma shows little spatial heterogeneity after adjusting for tumor purity (2020) (1)
- Neurooncology: 2021 update (2021) (1)
- [Neuroschistosomiasis; an unexpected finding in a Dutch woman]. (2009) (1)
- Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades (2022) (1)
- Abstract 5270: IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas (2015) (1)
- Scheie syndrome presenting as myopathy. (2001) (1)
- Fast intraoperative histology-based diagnosis of gliomas with third harmonic generation microscopy and deep learning (2022) (1)
- Paraneoplastic non-caseating granulomatous inflammation of the eyelid. (1995) (1)
- Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases (2014) (1)
- [Development and the developmental disorders of human brain. I. Early development of the cerebrum]. (2001) (1)
- Distribution of GOPC:ROS1 and other ROS1 fusions in glioma types (2021) (0)
- PATH-11. THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGODENDROGLIOMA IS DRIVEN BY TREATMENT-ASSOCIATED GENETIC ALTERATIONS (2022) (0)
- Oligodendroglial tumors: towards tailored therapy through the development of novel predictive diagnostic tools (2004) (0)
- Abstract 3426: A novel approach to copy number assessment by whole genome sequencing reveals extensive spatial heterogeneity in diffuse low-grade glioma (2014) (0)
- Granular Cell Tumour (2007) (0)
- Abstract 2077: Selective MET kinase inhibition in MET-dependent glioma models (2017) (0)
- Overcoming Temozolomide (TMZ) resistance in glioma (2013) (0)
- HIGH GRADE GLIOMAS AND DIPG (2014) (0)
- Grading of Meningeal Solitary Fibrous Tumors/Hemangiopericytomas: Prognostic Value of the Marseille Grading System in a Cohort of 132 Patients in correlation with molecular data (2019) (0)
- Ultra-fast deep-learned pediatric CNS tumor classification during surgery (2023) (0)
- Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol (2023) (0)
- EPID-18. TRENDS IN INCIDENCE AND SURVIVAL OF MALIGNANT PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS IN THE NETHERLANDS (2020) (0)
- HIGH GRADE GLIOMAS AND DIPG (2014) (0)
- P-5-607 Angiogenesis in meningioma (1997) (0)
- Optimizing the identification of anaplastic oligodendroglioma patients that benefit from adjuvant PCV chemotherapy using the Illumina platform: A further report from EORTC study 26951. (2013) (0)
- NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target (2022) (0)
- Abstract 642: A hypermethylated phenotype as predictive marker for response to PCV in anaplastic oligodendrogliomas. A report from EORTC study 26951. (2013) (0)
- Constitutioneel ‘mismatch repair’-deficiëntiesyndroom (2015) (0)
- Introduction and Outline of Thesis Chapter 1.1 Introductory Résumé Introduction and Outline of Thesis Chapter 1.2 Genetics and Pharmacogenomics of Diffuse Glioma (0)
- Multimodality imaging of Cerebral Schistosomiasis (2008) (0)
- Genotyping and phenotyping of distant breast cancer metastases (2011) (0)
- [Development and developmental disorders of the human brain. II. Development of the cerebral cortex and major tract systems]. (2001) (0)
- Glioblastoma: Pathology and genetics (2018) (0)
- Constitutional mismatch repair deficiency syndrome Background (2015) (0)
- P05.04.A Disconcordance between different molecular methods to assess homozygous deletion of theCDKN2A/B locus in IDH-mutant astrocytomas (2022) (0)
- INSP-02. WHO 2021 classification of CNS tumors (2022) (0)
- Clinical application of molecular analysis of oligodendroglial tumors (1998) (0)
- Angiogenesis in experimental melanoma metastasis in nude mice (1998) (0)
- Longitudinal molecular trajectories of diffuse glioma in adults (2019) (0)
- Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas (2014) (0)
- Fatal acute disseminated encephalomeningitis (ADEM) in a neonate (1998) (0)
- Corrigendum: MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic and therapeutic potential. J Pathol 2010; 222: 324–328 (2011) (0)
- TBIO-17. IMPLEMENTATION OF METHYLATION PROFILING FOR CNS TUMOR DIAGNOSIS IN THE PRINCESS MÁXIMA CENTER FOR PEDIATRIC ONCOLOGY, THE NETHERLANDS (2018) (0)
- MC13-0035 Generation and (genetic) characterization of pre-clinical glioma models for “targeted therapies” (2013) (0)
- Case Report: Primary Leptomeningeal Melanoma in a Patient with Neurocutaneous Melanosis (2013) (0)
- Advanced glioma and correlation with histological and molecular characteristics (2013) (0)
- PATH-48. THE DNA METHYLATION LANDSCAPE OF CORE AND PERIPHERAL DIFFUSE GLIOMA REGIONS SHOWS LITTLE SPATIAL SUBTYPE HETEROGENEITY AFTER CONSIDERING TUMOR PURITY (2019) (0)
- HGG-49. Gliomatosis cerebri in children: A collaborative report from the European Society for Pediatric Oncology (SIOPE) (2022) (0)
- A new technique for the assessment of the draining area of a cerebral vein. (1999) (0)
- Implementation of robust MLPA assays detecting prognostic and predictive DNA changes in different gliomas (2008) (0)
- Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype. (2020) (0)
- MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer author ( s ) list : (0)
- ICAM expression and microglial activation in Alzheimer senile plaques: Indicators of an inflammatory response (1994) (0)
- OS09.4.A Health-related quality of life in low-grade glioma survivors 26 years after diagnosis (2021) (0)
- Tumor-educated platelets allow for multiclass liquid biopsy-based diagnosis of cancer (2015) (0)
- Registration of molecular markers in population-based cancer registries: Hopes and hurdles. (2022) (0)
- PATH-45. INTEGRATION OF MULTI-REGION (EPI)GENOMICS WITH MULTIMODALITY ADVANCED IMAGING HIGHLIGHTS GLIOMA INTRATUMORAL HETEROGENEITY (2017) (0)
- Erratum to Progression of a Nelson’s adenoma to pituitary carcinoma; a case report and review of the literature (1999) (0)
- Glioma Through the Looking GLASS: the Glioma Longitudinal Analysis consortium, molecular evolution of diffuse gliomas (2017) (0)
- ESTABLISHMENT OF AN INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) REGISTRY (2014) (0)
- Novel Dutch FFI family with heterogeneous course and newly described histology (2012) (0)
- GE-08TARGETED NEXT GENERATION SEQUENCING OF ARCHIVAL FFPE SAMPLES FROM EORTC STUDY 26951 SHOWS STRONG PROGNOSTIC VALUE OF A MOLECULAR CLASSIFICATION IN LOCALLY DIAGNOSED GRADE III OLIGODENDROGLIOMA. (2014) (0)
- Allowance of tumor-educated platelets for multiclass liquid biopsy-based diagnosis of cancer (2015) (0)
- OS08.1.A Integrative molecular analysis of matched primary and recurrent IDH-mutant astrocytoma; an update from the GLASS-NL consortium (2022) (0)
- P3-167 Specific association of small heat shock proteins with the pathological features of Alzheimer's and Parkinson's disease brains (2004) (0)
- Multiplex Ligation-dependent Probe Amplification (2020) (0)
- SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas (2016) (0)
- OS05.5.A Methylation analysis of matched primary and recurrent IDHmt astrocytoma; an update from the Glioma Longitudinal Analysis NL (GLASS-NL) consortium (2021) (0)
- EP-1845: Integration of 7T MRI into image-guided radiotherapy of glioblastoma: a feasibility study (2016) (0)
- DNA methylation and survival differences associated with the type of IDH mutation in 1p/19q non-codeleted astrocytomas (2020) (0)
- Liquid Biopsy Diagnosis of CNS Metastases (2019) (0)
- ME-04SUBVENTRICULAR SPREAD OF DIFFUSE INTRINSIC PONTINE GLIOMA (2014) (0)
- PO-390 Image-guided stereotactic molecular profiling of samples taken in- and outside conventional tumour boundaries highlight extensive infiltration of tumour cells in diffuse gliomas (2018) (0)
- EPCO-09. STEREOTACTIC IMAGE-GUIDED EPIGENOME PROFILING REVEALS DIVERSE EVOLUTIONARY GROWTH ROUTES IN DIFFUSE GLIOMAS (2020) (0)
- Advanced Imaging in Glioma Treatment : Moving the Frontier (2020) (0)
- ATRT-18. SHH-SUBTYPE ATYPICAL TERATOID/RHABDOID TUMORS ARE SELECTIVELY SENSITIVE TO GEMCITABINE TREATMENT (2020) (0)
- The epigenetic evolution of gliomas is determined by their 1 IDH 1 mutation status and treatment regimen 2 3 (2021) (0)
- PERICYTES IN GLIOBLASTOMAS CONTRIBUTE TO ENZYMATIC DEGRADATION OF ANGIOTENSIN II (1998) (0)
- Abstract 3775: Identification of PHF6 as a temozolomide resistance factor in glioblastoma using mirConnX (2014) (0)
- P3-187 Endothelial cell activation and cerebral white matter lesions in an autopsy based study (2006) (0)
- 021 Morbus Scheie presenting as myopathy (1999) (0)
- Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors (2022) (0)
- MICROVASCULAR CELL-SUBSTRATUM INTEGRINS AND EXTRACELLULAR MATRIX PROTEINS IN HUMAN GLIOBLASTOMA MULTIFORME: 111 (1995) (0)
- Accumulation ofIntercellular Adhesion Molecule-1 inSenile Plaques inBrain Tissue ofPatients withAlzheimer's Disease (1994) (0)
- ATPS-84HYDROXYUREA SENSITIZES PATIENT-DERIVED GLIOBLASTOMA TUMORS TO TEMOZOLOMIDE IRRESPECTIVE OF MGMT STATUS (2015) (0)
- Reviewers for Cellular Oncology in 2009 The following scientists have served as reviewers for Cellular Oncology in the year 2009. In doing so they have made an important contribution to the journal, which we gratefully acknowledge. (2010) (0)
- Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’ (2022) (0)
- Prediction of progression in low-grade glioma using chromosomal copy number alterations (2013) (0)
- SURG-13. THIRD HARMONIC GENERATION (THG) IMAGING: A NOVEL TOOL FOR INTRA-OPERATIVE HISTOLOGIC ANALYSIS OF FRESH HUMAN GLIOMA TISSUE (2018) (0)
- EPCO-17. METHYLATION ANALYSIS OF MATCHED PRIMARY AND RECURRENT IDHmt ASTROCYTOMA; AN UPDATE FROM THE GLIOMA LONGITUDINAL ANALYSIS NL (GLASS-NL) CONSORTIUM (2021) (0)
- 383 Contribution of cytological CSF analysis to the management of patients with breast cancer; a retrospective analysis over two decades (2010) (0)
- QOLP-05. HEALTH-RELATED QUALITY OF LIFE IN LOW-GRADE GLIOMA SURVIVORS 26 YEARS AFTER DIAGNOSIS (2021) (0)
- P14.31 Between hospital variation in timings to multidisciplinary glioblastoma care in the Dutch Brain Tumor Registry (2021) (0)
- DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM (2018) (0)
- The molecular landscape of ETMR at diagnosis and relapse (2019) (0)
- Abstract 2793: A hypermethylated phenotype in anaplastic oligodendroglial brain tumors is a better predictor of survival than MGMT methylation in the EORTC 26951 study (2011) (0)
- Computer-assisted analysis of the micro vasculature in untreated glioblastomas* (1995) (0)
- P14.40 Trends in distribution of glioblastoma care and patient’s travel distance; results from the Dutch Brain Tumor Registry (2021) (0)
- Glial Brain Tumors: Antiangiogenic Therapy (2011) (0)
- Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification (2023) (0)
- Abstract 2168: Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2022) (0)
- PATH-23. OLIGOSARCOMA, IDH-MUTANT IS A DISTINCT AGGRESSIVE TYPE (2021) (0)
- GENE-60. THE EPITRANSCRIPTOMIC CODE IN LGG: METABOLICALLY REPROGRAMMED IDH-MUTANT GLIOMAS ALTER tRNA MODIFICATION LANDSCAPE (2019) (0)
- Protein arrays and metabolite biomarkers to predict development of RA and response to therapy (2013) (0)
- Molecular malignant progression in gliomas: elucidating their genetic ‘life story’ (2010) (0)
- [Constitutional mismatch repair deficiency syndrome]. (2015) (0)
- Top ten discoveries of the year: Neurooncology (2020) (0)
- The Cerebellum (2020) (0)
- ' s response to reviews Title : Upregulation of Claudin-4 , CAIX and GLUT1 in distant breast cancer metastases (2014) (0)
- NIMG-40. RAPID EARLY PROGRESSION (REP) OF GLIOBLASTOMA IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR: RESULTS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
- Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma (2016) (0)
- GNAQ mutation analysis might be useful in distinguishing between primary melanocytic lesions of the CNS and melanotic schwannomas (2010) (0)
- Curvilinear lipoma of the splenium. Case-illustration. (1999) (0)
- Successful third-line chemotherapy for an adult with recurrent medulloblastoma (2013) (0)
- IMMU-05. Integrative transcriptomic analysis of pilocytic astrocytomas reveals CNS region-associated characteristics (2022) (0)
- autolo-Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors (2009) (0)
- The Relationship between Genetic Aberrations as Detected by Comparative Genomic Hybridization and Vascularization in Glioblastoma Xenografts (2004) (0)
- PNR-09EVALUATION OF AGE-DEPENDENT TREATMENT STRATEGIES FOR CHILDREN AND YOUNG ADULTS WITH PINEOBLASTOMA: ANALYSIS OF POOLED SIOP-E AND HEAD START DATA (2016) (0)
- Abstract 3147: Stereotactic image-guided epigenome profiling reveals a neural stem cell evolutionary origin of diffuse gliomas (2021) (0)
- Some developmental disorders of the pyramidal tract. (1999) (0)
- EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection (2023) (0)
- HG-94TOXICITY AND EFFICACY OF CONVECTION-ENHANCED DELIVERY WITH LIPOSOMAL DOXORUBICIN IN DIPG AND THALAMIC PEDIATRIC HIGH GRADE GLIOMA MODELS. (2016) (0)
- p120-catenin-dependent collective brain infiltration by glioma cell networks (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pieter Wesseling?
Pieter Wesseling is affiliated with the following schools:
